Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia
Authors:
- 9 October 2015
- journal article
- Published by Springer Nature in Leukemia
- Vol. 29 (12) , 2427-2429
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemiaBlood, 2011
- The spectrum of large granular lymphocyte leukemia and Feltyʼs syndromeCurrent Opinion in Hematology, 2011
- How I treat LGL leukemiaBlood, 2011
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010
- Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemiaHaematologica, 2009
- Therapeutic targeting of Janus kinasesImmunological Reviews, 2008
- Regulation of JAK–STAT signalling in the immune systemNature Reviews Immunology, 2003
- Evolving concepts of rheumatoid arthritisNature, 2003
- Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionJournal of Clinical Investigation, 2001
- CYTOKINE RECEPTOR SIGNAL TRANSDUCTION AND THE CONTROL OF HEMATOPOIETIC CELL DEVELOPMENTAnnual Review of Cell and Developmental Biology, 1996